PI
Pharmstandard International Portfolio holdings
AUM $29M
1-Year Return
2.12%
This Quarter Return
-1.24%
1 Year Return
+2.12%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$29M
AUM Growth
+$4.13M
(+17%)
Cap. Flow
+$4.97M
Cap. Flow
% of AUM
17.13%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
–
Reduced
1
Closed
–
Top Buys
| 1 |
NTGN
Neon Therapeutics, Inc. Common Stock
NTGN
|
+$5.03M |
Top Sells
| 1 |
ALNA
Allena Pharmaceuticals, Inc. Common Stock
ALNA
|
+$54.8K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALNA
1
DELISTED
Allena Pharmaceuticals, Inc. Common Stock
ALNA
| $9.38M | 32.28% |
873,031
-5,100
| -0.6% | -$54.8K |
|
2
Protagonist Therapeutics
PTGX
$3.63B
| $7.72M | 26.59% |
750,632
| – | – |
|
|
NTGN
3
DELISTED
Neon Therapeutics, Inc. Common Stock
NTGN
| $5.03M | 17.31% |
+588,611
| New | +$5.03M |
|
|
JNCE
4
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $3.67M | 12.65% |
565,063
| – | – |
|
5
Protara Therapeutics
TARA
$122M
| $3.14M | 10.79% |
40,195
| – | – |
|
|
ARGS
6
DELISTED
Argos Therapeutics, Inc.
ARGS
| $83K | 0.29% |
826,153
| – | – |
|